HXHuiqin Xu

Huiqin Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests


Huiqin Xu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Chuanchuan He

    Department of Central Laboratory, Jiaxing Maternity and Child Health Care Hospital, Affiliated Women and Children Hospital, Jiaxing University, Jiaxing, People’s Republic of China

    1 shared publication
  • Liu Xu

    Affiliated Hospital of Jiaxing University, Jiaxing, China

    1 shared publication
  • Ruixue Ma

    Department of Pharmaceutics, College of Medicine, Jiaxing University, Zhejiang, China

    1 shared publication
  • Sirui Hang

    Zhejiang Chinese Medical University, Zhejiang, China

    1 shared publication
  • Xiaojuan Zhang

    Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, Department of Pharmaceutics, College of Medicine, Jiaxing University, Jiaxing 314001, China

    1 shared publication

Latest Publications

  • Open Access

    Recent advances in calcium peroxide nanomedicines for breast cancer treatment

    by Sirui Hang, Liu Xu, Ruixue Ma, Huiqin Xu, Xiaojuan Zhang, Chuanchuan He

    As a typical solid tumor, breast cancer is characterized by a tumor microenvironment featuring hypoxia, acidosis, and highly reductive conditions. These factors contribute to treatment resistance (e.g., chemoresistance) through various mechanisms, thereby diminishing therapeutic efficacy. Calcium peroxide (CaO2) can generate multiple bioactive molecules (metal ions, H2O2, O2, and OH−) in acidic or neutral environment, making it a promising biomaterial for cancer therapy. Recently, breast cancer has been extensively targeted using CaO2 nanoparticles in both cellular and murine models. In this review, we first provide a summary of strategies employing CaO2 nanomedicine-based breast cancer therapies, then discuss the obstacles and development directions of CaO2 application in breast cancer therapy.